FIS
FCPM III Services Portfolio holdings
AUM
$369M
This Quarter Return
-10.61%
1 Year Return
-29.21%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$369M
AUM Growth
+$369M
(-11%)
Cap. Flow
-$415K
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
1
Reduced
1
Closed
–
Top Buys
| 1 |
RAPT Therapeutics
RAPT
|
$3.45M |
| 2 |
Astria Therapeutics
ATXS
|
$1.62M |
Top Sells
| 1 |
NewAmsterdam Pharma
NAMS
|
$5.49M |
Sector Composition
| 1 | Healthcare | 99.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NewAmsterdam Pharma
NAMS
$2.71B
| $193M | 52.16% | 10,632,113 -303,197 | -3% | -$5.49M |
|
2
Dyne Therapeutics
DYN
$1.92B
| $52M | 14.09% | 5,462,846 | – | – |
|
3
Replimune Group
REPL
$422M
| $36.3M | 9.84% | 3,909,696 | – | – |
|
4
enGene Holdings
ENGN
$236M
| $35.1M | 9.5% | 9,632,561 | – | – |
|
|
BCYC
5
Bicycle Therapeutics
BCYC
$511M
| $24M | 6.5% | 3,452,330 | – | – |
|
|
6
Astria Therapeutics
ATXS
$349M
| $23.4M | 6.34% | 4,107,537 +285,000 | +7% | +$1.62M |
|
|
7
RAPT Therapeutics
RAPT
$188M
| $3.45M | 0.93% | +440,176 | New | +$3.45M |
|
|
8
enGene Holdings Inc. Warrants
ENGNW
$7.08M
| $2.36M | 0.64% | 2,878,148 | – | – |
|